News Column

Phlexglobal is sold for £42m

July 15, 2014

MICHAEL BOW



BRIDGEPOINT Development Capital yesterday bought a London-based pharmaceutical services company named Phlexglobal for 42m.


The group, which is the smaller arm of private equity group Bridgepoint, has agreed to take on Phlexglobal from seller Inflexion.


Phlexglobal makes software which supports clinical trials in the pharma sector. The group has revenue of 15.3m and operating earnings of about 4.5m.


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: City A.M. (UK)


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters